Your browser is old and is not supported. Upgrade for better security.

Invest in Nicolette

Empowering patients with data, rapid education, and participation tools

Pitch Video
Investor Panel

Highlights

1
🚀Mission: Transform healthcare by empowering patients with easy-to-use success tools.
2
🧩Founder Fit: Founded by NICU parents and physicians with deep knowledge of the patient journey.
3
👊Partners: Backed by Backstage Capital, Cedars-Sinai, Techstars, Boomtown, WM360, and more.
4
💥Competitive Advantages: Patent-pending tech, EHR integration, network effects, and first-mover.
5
🎯Execution: First implementation completed with breakthrough results at CHOC Children's Hospital.

Our Team

Phil and his wife Jude had extremely premature twins (25-weeks gestation) and struggled to navigate the NICU journey. They made decisions they would now do differently, they signed consents they didn't fully understand, and they missed valuable opportunities to participate in care. Their experience led to Phil co-founding Nicolette.

Nicolette empowers patients and their caregivers to be members of their own care team. Our technology transforms raw health data into insights, updates, curated education, and participation tools. ✅

Health literacy is the greatest tool available to empower patients and their caregivers to self-advocate and be part of their own care team:

We build data-driven technology that empowers patients through literacy.

Here is a demo of our first product, NicoBoard:

A patient is empowered when they are competent and confident.

The market for our technology is large with excellent scalability. We are starting in the NICU, which has many advantages.

Our business model is B2B SaaS, generating recurring revenue that scales well and carries excellent unit economics.

This slide contains forward-looking projections that cannot be guaranteed.

Health systems and insurance companies buy our technology because health outcomes improve and costs are reduced when patients are empowered.

Our first commercial contract is in place and installed, generating excellent results. We also have a channel deal signed and a large pipeline projected to close between five to ten deals in 2021 (not guaranteed).

This slide contains forward-looking projections that cannot be guaranteed.

We are a team of patients, clinicians, and product experts with deep experience in our areas of expertise. Most importantly, we are passionate about empowering patients with success tools.

We are crowdfunding a minimum of $100,000 to fuel growth and expand our product.

🤝 WE HOPE YOU'LL JOIN US IN TAKING OUR MISSION TO THE NEXT LEVEL 🚀

This slide contains forward-looking projections that cannot be guaranteed.

Overview